NYSE:CC - The Chemours Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.22
  • Forecasted Upside: 16.61 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$31.92
▲ +0.03 (0.09%)

This chart shows the closing price for CC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New The Chemours Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CC

Analyst Price Target is $37.22
▲ +16.61% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for The Chemours in the last 3 months. The average price target is $37.22, with a high forecast of $48.00 and a low forecast of $28.00. The average price target represents a 16.61% upside from the last price of $31.92.

This chart shows the closing price for CC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 10 investment analysts is to buy stock in The Chemours. This rating has held steady since April 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 8 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 7 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 8 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/30/2021BMO Capital MarketsBoost Price TargetOutperform$42.00 ➝ $48.00Low
6/9/2021Wolfe ResearchInitiated CoverageOutperformHigh
6/9/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$35.00 ➝ $47.00High
5/20/2021Bank of AmericaInitiated CoverageBuy$42.00Low
5/10/2021Morgan StanleyBoost Price TargetEqual Weight$30.00 ➝ $35.00Medium
5/6/2021ArgusUpgradeHold ➝ Buy$40.00High
2/17/2021CitigroupBoost Price Target$27.00 ➝ $29.00Low
2/16/2021BMO Capital MarketsBoost Price Target$33.00 ➝ $38.00Low
2/16/2021Morgan StanleyBoost Price TargetEqual Weight$28.00 ➝ $30.00Low
1/8/2021Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$27.00 ➝ $35.00High
12/14/2020Morgan StanleyBoost Price TargetEqual Weight$23.00 ➝ $28.00Medium
12/4/2020BarclaysDowngradeOverweight ➝ Equal Weight$26.00 ➝ $28.00Medium
11/30/2020Alembic Global AdvisorsInitiated CoverageOverweight$31.00High
11/16/2020Morgan StanleyBoost Price TargetEqual Weight$12.00 ➝ $23.00High
11/5/2020BMO Capital MarketsBoost Price TargetOutperform$26.00 ➝ $28.00High
11/5/2020BarclaysBoost Price TargetOverweight$22.00 ➝ $26.00High
8/4/2020CitigroupBoost Price TargetNeutral$16.00 ➝ $18.00Low
8/3/2020Royal Bank of CanadaBoost Price TargetSector Perform$15.00 ➝ $19.00High
8/3/2020BarclaysBoost Price TargetOverweight$16.00 ➝ $22.00High
7/9/2020UBS GroupBoost Price TargetNeutral$12.00 ➝ $15.00Medium
5/8/2020UBS GroupBoost Price TargetNeutral$9.00 ➝ $12.00Medium
5/7/2020SunTrust BanksBoost Price TargetHold$10.00 ➝ $12.00Low
4/14/2020Susquehanna BancsharesLower Price Target$23.00 ➝ $17.00High
4/9/2020CitigroupLower Price TargetNeutral$10.00 ➝ $8.00High
4/3/2020CfraLower Price TargetStrong-Buy ➝ Hold$21.00 ➝ $11.00Low
4/1/2020Royal Bank of CanadaLower Price TargetSector Perform$13.00 ➝ $11.00High
3/30/2020Morgan StanleyLower Price TargetEqual Weight$15.00 ➝ $12.00Medium
3/26/2020Royal Bank of CanadaReiterated RatingHold$13.00Medium
3/26/2020BMO Capital MarketsLower Price TargetOutperform$33.00 ➝ $21.00Low
3/25/2020SunTrust BanksLower Price TargetHold$19.00 ➝ $10.00High
3/23/2020Jefferies Financial GroupDowngradeBuy ➝ HoldHigh
2/19/2020Royal Bank of CanadaReiterated RatingHold$20.00Low
2/18/2020SunTrust BanksBoost Price TargetHold$17.00 ➝ $19.00Medium
2/14/2020CfraUpgradeBuy ➝ Strong-BuyHigh
12/22/2019Royal Bank of CanadaReiterated RatingHold$19.00Medium
12/20/2019JPMorgan Chase & Co.Lower Price TargetNeutral$21.00 ➝ $19.00High
11/6/2019CfraUpgradeHold ➝ BuyMedium
11/6/2019SunTrust BanksBoost Price TargetIn-Line ➝ Hold$20.00Medium
10/2/2019UBS GroupLower Price TargetNeutral$19.00 ➝ $14.50Low
9/9/2019BMO Capital MarketsLower Price TargetOutperform$31.00 ➝ $23.00High
8/20/2019Susquehanna BancsharesUpgradeNeutral ➝ Positive$37.00 ➝ $18.00Medium
8/9/2019Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$32.00 ➝ $16.00High
8/6/2019ArgusDowngradeBuy ➝ HoldMedium
8/5/2019SunTrust BanksDowngradeBuy ➝ HoldHigh
8/5/2019BMO Capital MarketsLower Price TargetOutperform$45.00 ➝ $31.00High
7/12/2019CitigroupDowngradeBuy ➝ Neutral$40.00 ➝ $20.00High
7/9/2019SunTrust BanksReiterated RatingBuyLow
6/24/2019BMO Capital MarketsSet Price TargetBuy$50.00 ➝ $45.00Low
6/19/2019Morgan StanleySet Price TargetHold$26.00High
6/10/2019Jefferies Financial GroupLower Price TargetBuy$48.00 ➝ $30.00Medium
6/3/2019BarclaysReiterated RatingBuy$42.00High
5/6/2019Royal Bank of CanadaLower Price TargetOutperform$43.00High
5/6/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$40.00 ➝ $34.00High
4/15/2019SunTrust BanksUpgradeHold ➝ Buy$40.00 ➝ $52.00High
2/20/2019CitigroupReiterated RatingBuy$43.00Medium
2/19/2019SunTrust BanksBoost Price TargetHold$40.00High
2/19/2019Susquehanna BancsharesReiterated RatingPositive ➝ Neutral$37.00Low
1/15/2019BarclaysReiterated RatingBuy$48.00Medium
1/8/2019HSBCInitiated CoverageBuy ➝ Buy$52.00Medium
1/4/2019CitigroupUpgradeNeutral ➝ BuyHigh
11/5/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$68.00 ➝ $58.00Low
11/5/2018Susquehanna BancsharesLower Price TargetPositive$65.00 ➝ $44.00Low
11/5/2018SunTrust BanksLower Price TargetHold$38.00Medium
11/2/2018CitigroupDowngradeBuy ➝ Neutral$44.00 ➝ $38.00High
10/11/2018CitigroupLower Price TargetBuy$61.00 ➝ $44.00High
9/25/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$48.00 ➝ $47.00Low
9/13/2018Royal Bank of CanadaReiterated RatingOutperformLow
8/7/2018BarclaysReiterated RatingBuy$62.00Medium
8/6/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$70.00 ➝ $68.00Low
7/31/2018SunTrust BanksInitiated CoverageHold$51.00Medium
7/18/2018Royal Bank of CanadaInitiated CoverageOutperform$60.00High
7/17/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$57.50 ➝ $48.00High
7/11/2018CitigroupLower Price TargetBuy ➝ Buy$69.00 ➝ $64.00High
5/21/2018Vertical ResearchInitiated CoverageBuyLow
5/8/2018CitigroupBoost Price TargetBuy ➝ Buy$66.00 ➝ $69.00Low
5/8/2018BarclaysReiterated RatingBuy$64.00Low
4/10/2018CitigroupLower Price TargetBuy ➝ Buy$68.00 ➝ $66.00Low
3/27/2018BMO Capital MarketsInitiated CoverageOutperform$68.00Medium
1/30/2018Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$57.50Medium
12/6/2017BarclaysReiterated RatingBuy$60.00Low
12/6/2017The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00Medium
12/4/2017Jefferies Financial GroupBoost Price TargetBuy$66.00High
11/6/2017BarclaysBoost Price TargetOverweight$55.00 ➝ $58.00N/A
11/3/2017UBS GroupBoost Price TargetNeutral$50.00 ➝ $59.00N/A
8/10/2017ArgusReiterated RatingBuy$50.00 ➝ $55.00High
8/7/2017UBS GroupUpgradeSell ➝ Neutral$36.00 ➝ $50.00Low
8/4/2017JPMorgan Chase & Co.Boost Price TargetOverweight$55.00Low
8/4/2017CitigroupBoost Price TargetBuy$45.00 ➝ $59.00High
8/3/2017Jefferies Financial GroupBoost Price TargetBuy$60.00High
7/13/2017Jefferies Financial GroupReiterated RatingBuy$48.00 ➝ $50.00Medium
7/5/2017CitigroupUpgradeNeutral ➝ Buy$43.00 ➝ $45.00Low
6/16/2017Jefferies Financial GroupReiterated RatingBuy$48.00Low
6/14/2017UBS GroupReiterated RatingSell$35.00 ➝ $36.00N/A
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 ➝ $55.00Low
5/12/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$39.00 ➝ $50.00High
4/17/2017CitigroupBoost Price TargetBuy$62.00 ➝ $63.00Medium
4/14/2017CitigroupReiterated RatingNeutral$34.00 ➝ $40.00N/A
3/29/2017Jefferies Financial GroupUpgradeHold ➝ Buy$35.00 ➝ $48.00Medium
2/17/2017Susquehanna BancsharesUpgradeNeutral ➝ Positive$40.00N/A
2/17/2017CitigroupUpgradeNeutral ➝ Positive$26.00 ➝ $40.00N/A
2/17/2017UBS GroupUpgradeNeutral ➝ PositiveN/A
2/15/2017Jefferies Financial GroupBoost Price TargetHold$25.00 ➝ $35.00N/A
2/13/2017The Goldman Sachs GroupUpgradeNeutral ➝ BuyN/A
12/12/2016The Goldman Sachs GroupDowngradeBuy ➝ Neutral$23.00 ➝ $27.00N/A
11/16/2016Jefferies Financial GroupBoost Price TargetHold$17.00 ➝ $25.00N/A
11/10/2016Jefferies Financial GroupReiterated RatingHold$15.00 ➝ $17.00N/A
9/1/2016Jefferies Financial GroupBoost Price TargetHold$10.00 ➝ $15.00N/A
8/11/2016CitigroupLower Price TargetNeutral$11.00 ➝ $9.00N/A
8/10/2016ArgusUpgradeHold ➝ Buy$13.00N/A
8/9/2016UBS GroupBoost Price TargetSell$5.00 ➝ $5.25N/A
(Data available from 7/23/2016 forward)
The Chemours logo
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
Read More

Today's Range

Now: $31.92
Low: $31.52
High: $32.41

50 Day Range

MA: $34.76
Low: $30.88
High: $37.88

52 Week Range

Now: $31.92
Low: $16.85
High: $38.87

Volume

536,652 shs

Average Volume

1,362,273 shs

Market Capitalization

$5.28 billion

P/E Ratio

24.74

Dividend Yield

3.14%

Beta

2.12

Frequently Asked Questions

What sell-side analysts currently cover shares of The Chemours?

The following sell-side analysts have issued stock ratings on The Chemours in the last twelve months: Alembic Global Advisors, Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Morgan Stanley, Royal Bank of Canada, The Goldman Sachs Group, Inc., TheStreet, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for CC.

What is the current price target for The Chemours?

9 Wall Street analysts have set twelve-month price targets for The Chemours in the last year. Their average twelve-month price target is $37.22, suggesting a possible upside of 16.6%. BMO Capital Markets has the highest price target set, predicting CC will reach $48.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $28.00 for The Chemours in the next year.
View the latest price targets for CC.

What is the current consensus analyst rating for The Chemours?

The Chemours currently has 3 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CC will outperform the market and that investors should add to their positions of The Chemours.
View the latest ratings for CC.

What other companies compete with The Chemours?

How do I contact The Chemours' investor relations team?

The Chemours' physical mailing address is 1007 MARKET STREET, WILMINGTON DE, 19801. The specialty chemicals company's listed phone number is 302-773-1000 and its investor relations email address is [email protected] The official website for The Chemours is www.chemours.com.